Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB

Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB

 

Sirona Biochem Corp. is delighted to announce the development of a promising new set of potential antiviral compounds that will undergo testing at the renowned International Centre for Genetic Engineering and Biotechnology (ICGEB). These compounds, generated by Sirona's subsidiary TFChem, aim to expand Sirona's existing library of antiviral drug candidates.

The ICGEB, located in Trieste, Italy, will utilize specialized assays developed at their Laboratory of Molecular Virology to screen a library of 18 newly produced candidates for their potential to inhibit SARS-CoV2. Leading the research program is Dr. Alessandro Marcello, a globally recognized authority in Human Virology.

Building upon the previous screening results of the initial 20 compounds, these newly selected candidates hold significant promise. Testing is scheduled to commence within the next month.